Chinook Therapeutics, Inc. (KDNY) Misses Q1 EPS by 6c

Chinook Therapeutics, Inc. (NASDAQ: KDNY) reported Q1 EPS of ($0.85), $0.06 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $1.83 million versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on Chinook Therapeutics, Inc. (KDNY) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction
• Costco Wholesale (COST) PT Raised to $1,040 at DA Davidson Following Q4 Earnings